Structure Therapeutics CSO Lin Xichen reports disposal of common shares worth $207,378.61 - GPCR News | RalliesStructure Therapeutics CSO Lin Xichen reports disposal of common shares worth $207,378.61
G
GPCR• Insider share sale and option exercise
- Structure Therapeutics Chief Scientific Officer Lin Xichen exercised share options for 11,817 ordinary shares at USD 0.34 on Aug. 18, 2026.
- Those shares were converted into 3,939 American Depositary Shares.
- Lin sold 3,939 American Depositary Shares on Aug. 18 at weighted-average prices of USD 53.13, USD 54.2, and USD 55.05.
- Directly held ordinary shares fell to 228,960; share options outstanding declined to 142,898.
- Lin ended the day with no American Depositary Shares.
LBRDP
•
